NASDAQ: CAMPCamp4 Therapeutics Corp Stock Ownership - Who owns Camp4 Therapeutics?
Insider buying vs selling
Have Camp4 Therapeutics Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| 5am Partners VI LLC | 10% Owner | 2024-10-15 | 909,090 | $11.00 | $10.00MBuy |
| Ah Equity Partners Bio I LLC | 10% Owner | 2024-10-15 | 545,454 | $11.00 | $6.00MBuy |
| Ah Equity Partners Bio I LLC | 10% Owner | 2024-10-15 | 181,818 | $11.00 | $2.00MBuy |
| Enavate Sciences GP LLC | 10% Owner | 2024-10-15 | 1,363,636 | $11.00 | $15.00MBuy |
| Amir Nashat | Director | 2024-10-15 | 909,090 | $11.00 | $10.00MBuy |
| Northpond Ventures II GP LLC | 10% Owner | 2024-10-15 | 763,636 | $11.00 | $8.40MBuy |
| Polaris Management Co VII LLC | 10% Owner | 2024-10-15 | 909,090 | $11.00 | $10.00MBuy |
| Polaris Management Co VII LLC | 10% Owner | 2024-10-15 | 909,090 | $11.00 | $10.00MBuy |
| Polaris Management Co VII LLC | 10% Owner | 2024-10-15 | 909,090 | $11.00 | $10.00MBuy |
| Andrew J. Schwab | Director | 2024-10-15 | 909,090 | $11.00 | $10.00MBuy |
CAMP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CAMP insiders and whales buy or sell their stock.
CAMP Shareholders
What type of owners hold Camp4 Therapeutics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Enavate Sciences GP LLC | 18.78% | 3,785,802 | $7.50M | Insider |
| Enavate Sciences GP LLC | 18.78% | 3,785,802 | $7.50M | Institution |
| 5am Venture Management LLC | 14.52% | 2,927,915 | $5.80M | Institution |
| 5am Partners VI LLC | 14.52% | 2,927,915 | $5.80M | Insider |
| Andrew J. Schwab | 13.02% | 2,625,145 | $5.20M | Insider |
| Northpond Ventures II GP LLC | 11.10% | 2,238,244 | $4.43M | Insider |
| Ah Equity Partners Bio I LLC | 10.54% | 2,125,339 | $4.21M | Insider |
| Ah Capital Management LLC | 10.54% | 2,125,339 | $4.21M | Institution |
| Harbourvest Partners LLC | 6.31% | 1,271,948 | $2.52M | Institution |
| Amir Nashat | 4.51% | 909,090 | $1.80M | Insider |
CAMP vs Biotech Stocks
Camp4 Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.